Ampio Pharmaceuticals, Inc. (33)
Browse by Contract Category
Contracts
-
Amendment No. 1 to Employment Agreement dated August 30, 2022 by and between Ampio Pharmaceuticals, Inc. and Michael A. Martino
(Filed With SEC on September 1, 2022)
-
Personal Services Agreement between the Registrant and Dr. Bar-Or, dated February 4, 2022
(Filed With SEC on May 16, 2022)
-
Specimen Common Stock Certificate of the Registrant
(Filed With SEC on March 29, 2022)
-
Placement Agent Agreement, dated December 13, 2021, by and between Ampio Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners
(Filed With SEC on December 15, 2021)
-
Research Services Agreement between the Registrant and Trauma Research LLC, dated February 4, 2022
(Filed With SEC on May 16, 2022)
-
Form of Indemnification Agreement between Ampio Pharmaceuticals, Inc. and certain directors, executive officers and key employees
(Filed With SEC on March 29, 2022)
-
Employment Agreement between Ampio Pharmaceuticals, Inc. and Daniel Stokely, dated October 11, 2021
(Filed With SEC on March 29, 2022)
-
Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Holli Cherevka, dated October 11, 2021
(Filed With SEC on March 29, 2022)
-
Employment Agreement by and between Ampio Pharmaceuticals, Inc. and Michael Macaluso, dated October 11, 2021
(Filed With SEC on March 29, 2022)
-
2019 Stock Incentive Plan and forms of option agreements
(Filed With SEC on March 29, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 15, 2021)
-
Form of Warrant
(Filed With SEC on December 15, 2021)
-
Employment Agreement, by and between Ampio Pharmaceuticals, Inc. and Michael Martino, dated November 22, 2021
(Filed With SEC on November 29, 2021)
-
Specimen Common Stock Certificate of the Registrant
(Filed With SEC on March 3, 2021)
-
2019 Stock Incentive Plan and forms of option agreements
(Filed With SEC on March 3, 2021)
-
Amendment No. 3 to Employment Agreement, dated July 13, 2020, between the Company and Daniel Stokely
(Filed With SEC on July 14, 2020)
-
Loan Agreement, dated April 16, 2020, by and between Key Bank National Association and Ampio Pharmaceuticals, Inc
(Filed With SEC on April 22, 2020)
-
Amendment No. 3 to Human Serum Albumin Ingredient Purchase and Sale Agreement among Ampio Pharmaceuticals, Inc., Octapharma USA, Inc. and Nova Biologics, Inc., effective as of...
(Filed With SEC on February 21, 2020)
-
Description of Capital Stock of Ampio Pharmaceuticals, Inc
(Filed With SEC on February 21, 2020)
-
Sales Agreement, dated as of February 20, 2020, by and among ThinkEquity, a division of Fordham Financial Management, Inc., Roth Capital Partners LLC and Ampio Pharmaceuticals, Inc
(Filed With SEC on February 20, 2020)
-
Employment Agreement, dated December 14, 2019, between the Company and Michael Macaluso
(Filed With SEC on December 18, 2019)
-
Amendment No. 2 to Employment Agreement, dated December 14, 2019, between the Company and Daniel Stokely
(Filed With SEC on December 18, 2019)
-
Amendment to Cancellation Agreement, dated November 7, 2019, between Ampio Pharmaceuticals Inc. and Daniel Stokely
(Filed With SEC on November 7, 2019)
-
Form of Warrant Exercise Agreement
(Filed With SEC on October 29, 2019)
-
Employment Agreement, dated September 16, 2019, between the Company and Holli Cherevka
(Filed With SEC on September 20, 2019)
-
Stock Option Cancellation and Grant Agreement for Executive, dated August 20, 2019, between the Company and Daniel Stokely
(Filed With SEC on August 23, 2019)
-
Amendment to Employment Agreement, dated August 20, 2019, between the Company and Daniel Stokely
(Filed With SEC on August 23, 2019)
-
Employment Agreement, dated July 9, 2019, between the Company and Daniel Stokely
(Filed With SEC on July 10, 2019)
-
Placement Agency Agreement, dated June 17, 2019, by and among Ampio Pharmaceuticals, Inc. and ThinkEquity, a division of Fordham Financial Management, Inc
(Filed With SEC on June 17, 2019)
-
Form of Lock-Up Agreement
(Filed With SEC on June 17, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 17, 2019)
-
Separation Agreement, dated as of June 13, 2019, between Ampio Pharmaceuticals, Inc. and Thomas E. Chilcott, III
(Filed With SEC on June 13, 2019)
-
Equity Distribution Agreement, dated as of April 12, 2019, by and between Canaccord Genuity LLC and Ampio Pharmaceuticals, Inc
(Filed With SEC on April 15, 2019)